Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1KC9H | ISIN: US57777L1044 | Ticker-Symbol: N/A
1-Jahres-Chart
BLAQCLOUDS INC Chart 1 Jahr
5-Tage-Chart
BLAQCLOUDS INC 5-Tage-Chart
GlobeNewswire (Europe)
139 Leser
Artikel bewerten:
(0)

Blaqclouds Inc.: Blaqclouds, Inc. (OTC: BCDS) Completes Acquisition of ZEUS Blockchain Partners, Inc.

Finanznachrichten News

ROBESONIA, Pa., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Blaqclouds, Inc. (OTC: BCDS) is pleased to announce the successful acquisition of ZEUS Blockchain Partners, Inc. ("ZEUS") from DMS Technology, Inc. This strategic acquisition solidifies Blaqclouds' position as a leader in blockchain innovation while significantly expanding its footprint in the rapidly evolving decentralized technology sector.

Under the terms of the agreement, Blaqclouds, Inc. acquired 100% of the issued and outstanding shares of ZEUS, representing 100,000,000 shares of ZEUS Common Stock. As consideration, Blaqclouds issued a one-year convertible promissory note valued at $750,000 with an annual interest rate of 6% and a conversion price of.00825.

The transaction successfully closed on December 8, 2024, following the satisfaction of all customary closing conditions. Effective immediately, ZEUS will be fully integrated into the Blaqclouds ecosystem, enabling a unified approach to blockchain solutions, fostering technological innovation, and strengthening Blaqclouds' presence in the decentralized finance (DeFi) space.

This acquisition highlights Blaqclouds' commitment to delivering innovative, scalable blockchain solutions to a global audience, further reinforcing its position as a leader in the blockchain industry.

Key Assets Acquired

As part of the acquisition, Blaqclouds has secured a comprehensive suite of blockchain and internet properties, including:

  1. ZEUSChainScan.io:
    • A Layer 1 EVM blockchain with a native token, ZEUSx, used for gas and transaction fees.
    • Features 3-second block times and processing speeds of up to 300,000 TPS.
  2. ZEUSx.io:
    • A Layer 2 decentralized exchange (DEX) for swapping and creating liquidity pools on the ZEUS Chain.
  3. ZEUSNFTx.io:
    • A Layer 2 NFT minting engine on the ZEUS Chain.
    • ZEUSx is the platform's native token.
  4. ZEUSxPay.io:
    • A Layer 2 crypto payment plugin that supports over 500 tokens across multiple networks, including ETH, BNB, ZEUS, BASE, MATIC, and AVAX.
    • Rebranded from DiVinciPay in Q3 2024, this platform integrates with WIX, WordPress, and custom code solutions for seamless payment processing.
  5. ShopwithCrypto.io:
    • A retail application enabling users to purchase gift cards from global merchants using cryptocurrency through ZEUSxPay.io.
  6. TheAlley.io:
    • A Layer 2 media application featuring resources for businesses accepting cryptocurrency, the Alley Cat Podcast, and a proprietary member chat platform.
  7. AmpleSwap.com:
    • A Layer 2 DEX built on the ZEUS, BNB, and ETH chains, utilizing AMPLE and ZEUSx tokens for transactions.

In addition, Blaqclouds has acquired a portfolio of over 1,000 blockchain-based domains that will serve as the foundation for future decentralized application (DApp) projects.

Strategic Rationale

This acquisition aligns with Blaqclouds' commitment to advancing blockchain innovation and leveraging ZEUS Blockchain Partners' expertise in creating scalable, secure, and efficient platforms. Together, the companies aim to accelerate blockchain adoption, expand product offerings, and maximize shareholder value.

Leadership Commentary

"We are thrilled to welcome ZEUS Blockchain Partners into the Blaqclouds family," said Marjorie Schaefer, CEO of Blaqclouds, Inc. "This acquisition represents a significant milestone in our journey to become a global leader in blockchain technology. ZEUS's robust platform and innovative approach align perfectly with our mission to drive growth and excellence."

A spokesperson from ZEUS Blockchain Partners added: "Joining Blaqclouds marks an exciting new chapter for ZEUS. Together, we will unlock new opportunities, accelerate blockchain adoption, and deliver unparalleled value to our customers and partners."

About Blaqclouds, Inc. (OTC: BCDS)

Blaqclouds, Inc. is a publicly traded company dedicated to developing innovative blockchain and decentralized solutions. The company focuses on leveraging technology to deliver scalable platforms, empower businesses, and create long-term shareholder value.

About ZEUS Blockchain Partners, Inc.

ZEUS Blockchain Partners, Inc. is a Colorado-based blockchain technology company specializing in decentralized finance (DeFi) and scalable blockchain ecosystems. ZEUS has pioneered innovative blockchain applications, providing secure and efficient solutions for businesses and individuals.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially from those projected. Blaqclouds, Inc. undertakes no obligation to update any forward-looking statements.

Media Contact:

Blaqclouds, Inc.
Email: hello@blaqclouds.io
Phone: 307-323-4430
Website: www.blaqclouds.io


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.